Xvivo Perfusion Balance Sheet Health
Financial Health criteria checks 6/6
Xvivo Perfusion has a total shareholder equity of SEK2.1B and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK2.3B and SEK195.0M respectively. Xvivo Perfusion's EBIT is SEK58.0M making its interest coverage ratio -0.8. It has cash and short-term investments of SEK450.0M.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | -0.8x |
| Cash | SEK 449.98m |
| Equity | SEK 2.08b |
| Total liabilities | SEK 195.02m |
| Total assets | SEK 2.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 3XV's short term assets (SEK828.1M) exceed its short term liabilities (SEK150.8M).
Long Term Liabilities: 3XV's short term assets (SEK828.1M) exceed its long term liabilities (SEK44.2M).
Debt to Equity History and Analysis
Debt Level: 3XV is debt free.
Reducing Debt: 3XV has no debt compared to 5 years ago when its debt to equity ratio was 1.1%.
Debt Coverage: 3XV has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 3XV has no debt, therefore coverage of interest payments is not a concern.